Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. [electronic resource]
Producer: 20011004Description: 249-58 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Epirubicin -- therapeutic use
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Remission Induction
- Survival Rate
- Treatment Failure
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.